OBJECTIVE: Recent studies have suggested that prediabetes is associated with an increased risk for cardiovascular disease (CVD) only among individuals with concomitant hypertension. RESEARCH DESIGN AND METHODS: We analyzed the association between prediabetes and CVD by hypertension status among 3,313 black adults in the Jackson Heart Study (JHS) without diabetes or a history of CVD at baseline (2000-2004). Prediabetes was defined as fasting plasma glucose between 100 and 125 mg/dL or hemoglobin A1c between 5.7 and 6.4% (39 and 46 mmol/mol). Hypertension was defined as systolic/diastolic blood pressure ≥140/90 mmHg and/or self-reported antihypertensive medication use. Participants were followed for incident CVD events and all-cause mortality through 31 December 2014. RESULTS: Overall, 35% of JHS participants did not have prediabetes or hypertension, 18% had prediabetes alone, 22% had hypertension alone, and 25% had both prediabetes and hypertension. Compared with participants without either condition, the multivariable-adjusted hazard ratios for CVD events among participants with prediabetes alone, hypertension alone, and both prediabetes and hypertension were 0.86 (95% CI 0.51, 1.45), 2.09 (1.39, 3.14), and 1.93 (1.28, 2.90), respectively. Among participants with and without hypertension, there was no association between prediabetes and an increased risk for CVD (0.78 [0.46, 1.34] and 0.94 [0.70, 1.26], respectively). No association was present between prediabetes and all-cause mortality among participants with or without hypertension. CONCLUSIONS: Regardless of hypertension status, prediabetes was not associated with an increased risk for CVD or all-cause mortality in this cohort of black adults.
OBJECTIVE: Recent studies have suggested that prediabetes is associated with an increased risk for cardiovascular disease (CVD) only among individuals with concomitant hypertension. RESEARCH DESIGN AND METHODS: We analyzed the association between prediabetes and CVD by hypertension status among 3,313 black adults in the Jackson Heart Study (JHS) without diabetes or a history of CVD at baseline (2000-2004). Prediabetes was defined as fasting plasma glucose between 100 and 125 mg/dL or hemoglobin A1c between 5.7 and 6.4% (39 and 46 mmol/mol). Hypertension was defined as systolic/diastolic blood pressure ≥140/90 mmHg and/or self-reported antihypertensive medication use. Participants were followed for incident CVD events and all-cause mortality through 31 December 2014. RESULTS: Overall, 35% of JHS participants did not have prediabetes or hypertension, 18% had prediabetes alone, 22% had hypertension alone, and 25% had both prediabetes and hypertension. Compared with participants without either condition, the multivariable-adjusted hazard ratios for CVD events among participants with prediabetes alone, hypertension alone, and both prediabetes and hypertension were 0.86 (95% CI 0.51, 1.45), 2.09 (1.39, 3.14), and 1.93 (1.28, 2.90), respectively. Among participants with and without hypertension, there was no association between prediabetes and an increased risk for CVD (0.78 [0.46, 1.34] and 0.94 [0.70, 1.26], respectively). No association was present between prediabetes and all-cause mortality among participants with or without hypertension. CONCLUSIONS: Regardless of hypertension status, prediabetes was not associated with an increased risk for CVD or all-cause mortality in this cohort of black adults.
Authors: David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: Herman A Taylor; James G Wilson; Daniel W Jones; Daniel F Sarpong; Asoka Srinivasan; Robert J Garrison; Cheryl Nelson; Sharon B Wyatt Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Adam P Bress; Jordan B King; Kathryn E Kreider; Srinivasan Beddhu; Debra L Simmons; Alfred K Cheung; Yingying Zhang; Michael Doumas; John Nord; Mary Ellen Sweeney; Addison A Taylor; Charles Herring; William J Kostis; James Powell; Anjay Rastogi; Christianne L Roumie; Alan Wiggers; Jonathan S Williams; Reem Yunis; Athena Zias; Greg W Evans; Tom Greene; Michael V Rocco; William C Cushman; David M Reboussin; Mark N Feinglos; Vasilios Papademetriou Journal: Diabetes Care Date: 2017-08-09 Impact factor: 19.112
Authors: Emmanuel Keku; Wayne Rosamond; Herman A Taylor; Robert Garrison; Sharon B Wyatt; Michelle Richard; Brenda Jenkins; Lisa Reeves; Daniel Sarpong Journal: Ethn Dis Date: 2005 Impact factor: 1.847
Authors: Leigh Perreault; Marinella Temprosa; Kieren J Mather; Ed Horton; Abbas Kitabchi; Mary Larkin; Maria G Montez; Debra Thayer; Trevor J Orchard; Richard F Hamman; Ronald B Goldberg Journal: Diabetes Care Date: 2014-06-26 Impact factor: 19.112
Authors: Arjun Sinha; Hongyan Ning; Faraz S Ahmad; Michael P Bancks; Mercedes R Carnethon; Matthew J O'Brien; Norrina B Allen; John T Wilkins; Donald M Lloyd-Jones; Sadiya S Khan Journal: Cardiovasc Diabetol Date: 2021-03-22 Impact factor: 8.949
Authors: Nrupen A Bhavsar; Clemontina A Davenport; Lexie Zidanyue Yang; Sarah Peskoe; Julia J Scialla; Rasheeda K Hall; Crystal C Tyson; Tara Strigo; Mario Sims; Jane Pendergast; Lesley H Curtis; L Ebony Boulware; Clarissa J Diamantidis Journal: BMC Nephrol Date: 2021-11-11 Impact factor: 2.388
Authors: Li Zhao; Rani Zierath; Jenine E John; Brian Lee Claggett; Michael E Hall; Donald Clark; Kenneth R Butler; Adolfo Correa; Amil M Shah Journal: JAMA Netw Open Date: 2022-09-01